Skip to main content
. 2021 Oct 21;2021:8851354. doi: 10.1155/2021/8851354

Table 3.

Estimated and calculated OS and LR for each case with and without PERSARC.

Case Treatment proposal OS/LR MDT estimation (%) OS/LR PERSARC prognosis (%) ∆ prognosis (∆—% absolute)
OS LR OS LR ∆OS ∆LR
1 R1 92.5 30.0 74.2 22.8 18.3 7.2
4 Neoadjuvant RT, R1 82.5 5.0 41.1 15.8 41.4 −10.8
6 Neoadjuvant RT, R1 27.5 20.0 14.0 20.4 13.5 −0.4
7 Neoadjuvant RT, R1 70.0 12.5 55.4 13.6 14.6 −1.1
8 R0 20.0 17.5 25.9 13.1 −5.9 4.4
9 Neoadjuvant RT, R1 40.0 15.0 77.0 10.0 −37.0 5.0
10 Neoadjuvant RT, R2 65.0 17.5 71.7 15.3 −6.7 2.2
13 Neoadjuvant RT, R1 82.5 5.0 72.7 10.9 9.8 −5.9
14 Neoadjuvant RT, R2 57.5 22.5 29.9 24.3 27.6 −1.8
15 Neoadjuvant RT, R0 65.0 17.5 81.3 2.9 −16.3 14.6
16 Neoadjuvant RT, R0 80.0 5.0 71.1 5.0 8.9 0.0
17 Neoadjuvant RT, R1 82.5 12.5 80.4 8.7 2.1 3.8
18 Neoadjuvant RT, R0 72.5 7.5 76.7 4.4 −4.2 3.1
19 R0 70.0 45.0 54.7 13.9 15.3 31.1
20 Neoadjuvant RT, R0 72.5 10.0 79.0 2.3 −6.5 7.7
21 Neoadjuvant RT, R0 80.0 5.0 77.0 4.8 3.0 0.2
22 Neoadjuvant RT, R0 75.0 10.0 57.6 6.6 17.4 3.4
23 Neoadjuvant RT, R1 62.5 12.5 49.2 10.0 13.3 2.5
24 R1, adjuvant RT 17.5 55.0 37.1 29.9 −19.6 25.1
25 Neoadjuvant RT, R1 40.0 22.5 70.7 7.8 −30.7 14.7
26 Neoadjuvant RT, R1 60.0 20.0 79.7 9.3 −19.7 10.7
27 Neoadjuvant RT, R1 60.0 10.0 71.8 10.0 −11.8 0.0
28 R2 12.5 100.0 28.9 27.3 −16.4 72.7
29 Neoadjuvant RT, R0 65.0 10.0 41.8 4.9 23.2 5.1
30 Neoadjuvant RT, R1 15.0 30.0 44.0 10.2 −29.0 19.8
31 Neoadjuvant RT, R0 85.0 10.0 77.9 3.0 7.1 7.0
32 R2 5.0 30.0 17.1 52.8 −12.1 −22.8
33 Neoadjuvant RT, R1 20.0 20.0 53.1 12.9 −33.1 7.1
34 Neoadjuvant RT, R1 35.0 25.0 59.4 9.4 −24.4 15.6
35 Neoadjuvant RT, R0 60.0 10.0 66.6 5.5 −6.6 4.5
36 Neoadjuvant RT, R0 65.0 10.0 79.9 4.3 −14.9 5.7

RT: radiotherapy.